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Abstract. We reported one neurocysticercosis (NCC) case who visited neurological outpatient clinic of Sanglah 
hospital, Denpasar, Bali. The patient is a 46-year-old man from Sumba, East Nusa Tenggara Province, and 
eastern part of Indonesia. The main symptoms of patient was headache and history of epileptic seizures, and 
spastic monoparesis on left lower limb. Diagnosis and follow up patient was performed clinically including CT 
scan and serologically. Detection of specific antibodies to Taenia solium in serum was performed by ELISA and 
immunoblot using native and recombinant antigens.   
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INTRODUCTION 
 
Bali is one of three known endemic 
provinces for taeniasis/cysticercosis in 
Indonesia.1,2 Cases of Taenia solium 
taeniasis, subcutaneous cysticercosis and 
neurocsticercosis were reported during 
1960-20143. Cases with taeniasis and 
cysticercosis have also reported from East 
Nusa Tenggara Province, eastern part of 
Indonesia2,4. In this report, we describe 
one neurocysticercosis (NCC) case who 
visited neurological outpatient clinic of 
Sanglah hospital, Denpasar, Bali a few 
years ago. 
 
CASE REPORT 
A 46 years-old man, Waikabubak, 
Sumba, East Nusa Tenggara Province, 
eastern part of Indonesia, visited 
neurological outpatient clinic, Sanglah 
hospital with history of headache, focal 
tonic clinic seizures on left lower limb 
followed by generalized seizures. He also 
complained a weakness on left lower limb 
and deteriorated gradually. He had been 
taken 600 mg carbamazepin and 60 mg 
phenobarbital dailies for 3 years. On 
general examination, there was no 
abnormality in respiratory and 
cardiovascular systems. A detailed 
neurological examination revealed that he 
presented spastic monoparesis on left 
lower limb with muscle strength 4, atrophy 
and hyper reflexia. Funduscopy showed 
papil oedema bilaterally. Laboratory data 
included routine blood tests, eosinophils 
and faecal examination were normal. CT 
scan showed multiple cystic lesions with 
scolex (Figure 1a). Serological 
examination (ELISA and immunoblot) was 
positive (Table). The patient was 
diagnosed as definitive neurocysticercosis 
(NCC). He refused to be hospitalized, 
however we treated him with 800 mg 
albendazole for one month, 15 mg 
dexametasone, 600 mg  carbamazepin, 
and 200 mg phenobarbital dailies, 
respectively. The patient was free of 
seizures for 2 months. However around 
one month after treatment,  he suffered 
from two episodes of seizures on left 
lower limb for last 3 minutes. Repeated 
treatment was performed with 800 mg 
albendazole daily for one month, and 3 
month afterwards CT scan showed 
multiple cystic lesions with scolex and one 
cystic lesion was degraded to calcified 
lesion (Figure 1b). No serum sample was 
available for serological evaluation of this 
patient. 
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                       Figure 1a.                                                                                 Figure 1.b 
 
Tabel 1. Serological examination for detection of antibodies against T. solium cysticercosis by 
both ELISA (using native with different glycoprotein T. solium and recombinant antigens) 
and immunublot. 
 
 
 
NCC 
Case 
ELISA OD Value, 405 nm (+/-)  
 
Immunoblot Native antigen Recombinant 
Antigen Cutt 
off=0.093 
Asian Genotype 
Cut of =0.051 
American 
Genotype Cut of 
=0.071 
African 
Genotype Cut of 
=0.072 
Patien
t 
0.057 (+) 0.191 (+) 0.099 (+) 0.191 (+) Positve 
NCC=Neurocysticercosis 
 
DISCUSSIONS 
 
We examined one patient of 
neurocysticercosis at Sanglah hospital, 
Denpasar, Bali. The patient from East 
Nusa Tenggara, eastern part  province of 
Indonesia which is also known as sporadic  
province for taeniasis/ cysticercosis.9   
The main symptom of patient was 
headaches, history of epileptic seizures 
for 8 months years duration, and spastic 
monoparesis on left lower limb.  
CT Scan was found cystic lesions with 
bright nodule within the cyst, identified as 
scolex, they were diagnosed as definitive 
NCC.  
Serological examination for detection of 
antibodies against T. solium cysticercosis 
revealed that the patient was positive by 
both ELISA (using native with different 
glycoprotein T. solium and recombinant 
antigens) and immunublot (Table). Follow 
up serology was found  still positive. It was 
suggested to repeat serology tests of this 
patient in next 1 or 2 years, and as such 
would be expected to be negative (Sudewi 
et al, unpublished data). 
Considering of the imaging techniques 
can not possibly show typical figures of 
neurocysticercosis, this examination is still 
high cost for most people in developing 
countries13, and in case where 
cerebrospinal fluid (CSF) is unavailable 
due to the patients refused spinal tap 
examination, serological examinations to 
detect antibody in serum samples are to 
be useful not only for supporting diagnosis, 
but also follow up patients. Recently, 
sensitivity and specificity of ELISA and 
immunoblot are developed14, for detects 
specific antibodies either in sera or CFS, 
although the limitation of this test is can be 
false negative result in patient with single 
nodule or inactive lesion. 
Albendazole was effective treatment for 
NCC patients with viable cysticerci and 
seizures have been controlled with 
phenytoin.  
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